Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
Utovlan 5 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. White, flat, circular, bevel-edged tablet inscribed ‘SEARLE’ on one side and ‘U’ on the other. |
Each tablet contains 5mg norethisterone.
Excipient(s) with known effect: Each tablet contains 62.25 mg lactose (as monohydrate).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Norethisterone |
Norethisterone has progestational actions similar to those of progesterone, but is a more potent inhibitor of ovulation and has weak oestrogenic and androgenic properties. It is used to treat a number of disorders of the menstrual cycle. |
| List of Excipients |
|---|
|
Maize starch |
Pvc/foil blister packs of 30 and 90 tablets.
Not all pack sizes may be marketed.
Pfizer Limited, Ramsgate Road, Sandwich, Kent CT13 9NJ, UK
PL 00057/1054
Date of first authorisation: 15th July 2002
Date of latest renewal: 15th February 2003
| Drug | Countries | |
|---|---|---|
| UTOVLAN | United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
